Pradžia › Smegenų ligos › Ohio
Smegenų ligos klinikiniai tyrimai Ohio
7 tyrimai dėl Smegenų ligos ieško dalyvių vietose Ohio.
Miestai Ohio
Oficialus tyrimo tekstas (anglų kalba)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Dayton
- Clinical Site, Independence
Renkami dalyviai2 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06887192CoMind Early Feasibility Study
- Ohio State University, Columbus
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT06368648A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #051, Canton
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07804615Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Miami Valley Hospital South, Centerville
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT05386108A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, North Canton
- Clinical Site, West Chester
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
- Akron Children's Hospital, Akron
- Cleveland Clinic, Cleveland
- Case Western Reserve University, Clevland
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2026-02-04 · NCT01694940Epilepsy Learning Healthcare System (ELHS)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Comprehensive Epilepsy Center (CCHMC), Cincinnati
- University of Cincinnati Gardner Neuroscience Institute Epilepsy Center, Cincinnati
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2024-08-30 · NCT06265103Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.